Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
<p>Abstract</p> <p>A response to and comment on <b>The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury</b>, by Haleema Shakur, Ian Roberts, et al.</p>
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-12-01
|
| Series: | Trials |
| Online Access: | http://www.trialsjournal.com/content/10/1/110 |